课题基金 / 基金详情

Commercialization of cavitation-enhancing nanodroplets for DNA sample fragmentation in NGS applications

Commercialization of cavitation-enhancing nanodroplets for DNA sample fragmentation in NGS applications
用于 NGS 应用中 DNA 样品碎片化的空化增强纳米液滴的商业化
批准号:
10081304
负责人:
Sandeep Kasoji
金额:
$84.47万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-07-05 至 2022-08-31

项目摘要

项目成果

Sandeep Kasoji的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY The completion of the Human Genome Project has established NGS as the gold standard technology for personalized/precision medicine and diagnostics. Genetic testing kits are now as readily available as pregnancy test kits, and advances in genetic analysis, gene therapy, and genetic modification in the 21st century promise to parallel the development of transistors and integrated circuits in the 20th century. The challenge is that technology for preparing biological samples for sequencing has not maintained a similar rapid advancement to gene sequencing. Fragmentation of DNA randomly without bias is an essential, but difficult step in the preparation of genomic DNA for NGS applications. A narrow range of DNA fragment lengths is required for sequencing, and inefficient or inconsistent fragmentation will result in incomplete or excluded reads, corrupting the sequencing. Sonication, which fragments DNA through cavitation, is the gold standard for DNA fragmentation. However, our customer discover interviews have reinforced that this is a significant pain point in their sample preparation process due to its low throughput and inconsistency, particularly for industry developing large-scale sequencing efforts. We have invented a novel nanodroplet reagent that enhances cavitation from an acoustic sonicator, and greatly improves consistency and reduces time and acoustic power requirements for DNA fragmentation. Triangle Biotechnology has licensed the patents describing this cavitation enhancing technology. We have achieved milestones proposed in Phase I, demonstrating product and technical feasibility. With this SBIR Phase II, we will perform key R&D tasks, product development, and validation studies to prepare for commercialization. Success of this project will enable a novel commercial solution for addressing market pain points: substantially improving throughput and consistency of DNA fragmentation for NGS sample preparation while reducing cost.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Improving diagnostic sensitivity for difficult-to-lyse microbial samples with nanodroplet technology
  • 批准号:
    10484601
  • 项目类别:
  • 资助金额:
    $100.0万
  • 财政年份:
    2020
  • 负责人:
    Sandeep Kasoji
  • 依托单位:
Improving diagnostic sensitivity for difficult-to-lyse microbial samples with nanodroplet technology
  • 批准号:
    10081308
  • 项目类别:
  • 资助金额:
    $25.21万
  • 财政年份:
    2020
  • 负责人:
    Sandeep Kasoji
  • 依托单位:
Improving diagnostic sensitivity for difficult-to-lyse microbial samples with nanodroplet technology
  • 批准号:
    10628013
  • 项目类别:
  • 资助金额:
    $99.84万
  • 财政年份:
    2020
  • 负责人:
    Sandeep Kasoji
  • 依托单位:
Commercialization of cavitation-enhancing nanodroplets for DNA sample fragmentation in NGS applications
  • 批准号:
    10259765
  • 项目类别:
  • 资助金额:
    $115.47万
  • 财政年份:
    2018
  • 负责人:
    Sandeep Kasoji
  • 依托单位:
海外基金